Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
209 Results for "
RAD
" in MedChemExpress (MCE) Product Catalog:
Products (209)
209 Results for "RAD" in MCE Product Catalog:
Cat. No.: HY-150958
RAD51-IN-8, a new RAD51 binder, is a RAD51-BRCA2 inhibitor that inhibits the RAD51 BRCA2 protein protein interaction. RAD51-IN-8 also is a protein−protein interaction (PPI) inhibitor. RAD51-IN-8 has inhibitory activity for H4A4 with an EC50 value of 19 μM .
RAD51-IN-5 is a potent inhibitor of RAD51. RAD51 is a eukaryote gene. RAD51-IN-5 has the potential for the research of conditions involving mitochondrial defects (extracted from patent WO2021164746A1, compound 3) .
Cat. No.: HY-162104
CAS No.: 2830213-53-9
BRCA2-RAD51-IN-1 (Compound 46) is a BRCA2-RAD51 inhibitor with an EC50 value of 28 μM. BRCA2-RAD51-IN-1 has antitumor activity .
Cat. No.: HY-19822S
Synonyms: RAD1901-d4
Cat. No.: HY-10218S1
CAS No.: 1661009-29-5
Synonyms: RAD001-13C2,d4; SDZ-RAD-13C2,d4
Cat. No.: HY-169622
CAS No.: 103056-35-5
RAD51-IN-9 (Compound 3a) is a RAD51 inhibitor that can inhibit the binding of RAD51 to ssDNA with an IC50 of 17.85 μM. RAD51-IN-9 has a LD50 against HEK293 cells of 40.21 μM. RAD51-IN-9 can sensitize cells to Mitomycin C (HY-13316) .
Cat. No.: HY-143737
CAS No.: 2690367-57-6
RAD51-IN-6 is a potent inhibitor of RAD51. RAD51 is a eukaryote gene. RAD51-IN-6 has the potential for the research of conditions involving mitochondrial defects (extracted from patent WO2021164746A1, compound 23) .
Cat. No.: HY-143741
CAS No.: 2690368-52-4
RAD51-IN-7 is a potent inhibitor of RAD51. RAD51 is a eukaryote gene. RAD51-IN-7 has the potential for the research of conditions involving mitochondrial defects (extracted from patent WO2021164746A1, compound 71) .
Cat. No.: HY-143735
CAS No.: 2267336-26-3
RAD51-IN-4 is a potent inhibitor of RAD51. RAD51 is a eukaryote gene. RAD51-IN-4 has the potential for the research of conditions involving mitochondrial defects (extracted from patent WO2019014315A1, compound R12) .
Cat. No.: HY-P10931
RAD21 (356–395) is a peptide encompassing amino acids 356 to 395 of the RAD21 protein, which can be used to study the interaction mechanism between STAG1 and RAD21. The equilibrium dissociation constant (KD) value for the interaction between RAD21 (356–395) and STAG1 is 127 nM .
Cat. No.: HY-P10931F
Target:
Research Areas:
RAD21 (356–395), biotin labeled is biotin-labeled RAD21 (356–395) (HY-P10931). RAD21 (356–395) is a peptide encompassing amino acids 356 to 395 of the RAD21 protein, which can be used to study the interaction mechanism between STAG1 and RAD21. The equilibrium dissociation constant (KD) value for the interaction between RAD21 (356–395) and STAG1 is 127 nM .
Cat. No.: HY-P11066
CAS No.: 1016899-40-3
Target:
Research Areas:
Cat. No.: HY-RS11596
Target:
Research Areas:
RAD1 Human Pre-designed siRNA Set A contains three designed siRNAs for RAD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11597
Target:
Research Areas:
RAD17 Human Pre-designed siRNA Set A contains three designed siRNAs for RAD17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11598
Target:
Research Areas:
RAD18 Human Pre-designed siRNA Set A contains three designed siRNAs for RAD18 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11599
Target:
Research Areas:
RAD21 Human Pre-designed siRNA Set A contains three designed siRNAs for RAD21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11602
Target:
Research Areas:
RAD50 Human Pre-designed siRNA Set A contains three designed siRNAs for RAD50 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11603
Target:
Research Areas:
RAD51 Human Pre-designed siRNA Set A contains three designed siRNAs for RAD51 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11604
Target:
Research Areas:
Rad51 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Rad51 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11605
Target:
Research Areas:
Rad51 Rat Pre-designed siRNA Set A contains three designed siRNAs for Rad51 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
